Gesynta Pharma has randomised half of the planned patients in [...]

PhoreMost has unveiled its lead oncology programme, PMC-001, as the [...]

Dicot Pharma has secured approximately SEK 231M (€21M) in gross [...]

Medable has launched a new support programme aimed at helping [...]

Quotient Sciences has begun a Phase 1 clinical study evaluating [...]

Patients across South Florida are set to gain greater access [...]

Veristat has agreed to acquire Certara’s regulatory and medical writing [...]

Allucent has appointed new therapeutic strategy leaders across key disease [...]

Aravax has appointed two senior industry figures to its board [...]

Hansa Biopharma’s Biologics License Application (BLA) for imlifidase has been [...]